Promising COVID-19 pill is less effective than initially reported
https://newatlas.com/health-wellbeing/merck-coronavirus-pill-molnupiravir-final-trial-efficacy-fda/
Promising COVID-19 pill is less effective than initially reported https://newatlas.com/health-wellbeing/merck-coronavirus-pill-molnupiravir-final-trial-efficacy-fda/
NEWATLAS.COM
Promising COVID-19 pill is less effective than initially reported
Ahead of a U.S Food and Drug Administration advisory panel meeting, drugmaker Merck has revealed final analysis data from a Phase 3 trial testing its oral antiviral pill against COVID-19. The new data reveals the treatment is significantly less effective than early indications.
Like
Haha
3
1 Комментарии 0 Поделились 845 Просмотры
Спонсоры

We are 100% funded for October.

Thanks to everyone who helped out. 🥰

Xephula monthly operating expenses for 2024 - Server: $143/month - Backup Software: $6/month - Object Storage: $6/month - SMTP Service: $10/month - Stripe Processing Fees: ~$10/month - Total: $175/month

Xephula Funding Meter

Please Donate Here